Form 4: Patterson Companies CEO Donald Zurbay Reports Stock Transactions
SEC Form 4
Donald Zurbay, President & CEO of Patterson Companies, reports multiple transactions involving company stock, including acquisitions, disposals, and option grants.
Summary
- Donald Zurbay, the President & CEO of Patterson Companies, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- The reported transactions occurred on July 1, 2024, and include the withholding of shares to cover tax liabilities related to restricted stock units (RSUs) and performance share units.
- Zurbay also acquired shares upon the satisfaction of performance criteria related to performance share units and received an award of RSUs.
- The filing also details Zurbay's holdings of employee stock options granted at various dates and exercise prices.
- Following the reported transactions, Zurbay directly owns 243,163 shares of common stock and indirectly owns 1,198 shares through an Employee Stock Ownership Plan (ESOP).
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing primarily reflects routine stock transactions related to executive compensation. The acquisition of shares upon meeting performance criteria is a slightly positive signal.
Positives
- The acquisition of 15,973 shares upon satisfaction of performance criteria suggests that the company is meeting its performance goals.
- The grant of 94,477 RSUs to the CEO indicates a continued investment in the company's leadership and aligns their interests with shareholders.
Future Outlook
The RSUs awarded on 7/1/2024 vest over the next three years, contingent upon continued employment, suggesting a long-term commitment from the CEO.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's sentiment and confidence in the company's future prospects.
Comparison to Industry Standards
- Stock option grants and RSU awards are common compensation practices among publicly traded companies, particularly for executive-level employees.
- The vesting schedules for the RSUs (33.3% annually over three years) are fairly standard in the industry.
- Comparing the size of the RSU grant and stock option holdings to those of CEOs at similarly sized companies in the healthcare distribution industry (e.g., Henry Schein, Cardinal Health) could provide a benchmark for assessing the competitiveness of Patterson Companies' executive compensation.
Stakeholder Impact
- The transactions have a minor impact on shareholders, primarily through the dilution effect of the RSU grants.
- Employees holding stock options and RSUs are directly impacted by the vesting schedules and stock price performance.
Key Dates
| Date | Description |
|---|---|
| 06/29/2018 | Date of grant for some employee stock options. |
| 07/01/2018 | Date of grant for some employee stock options. |
| 07/01/2019 | Date of grant for some employee stock options. |
| 07/14/2020 | Date of grant for some employee stock options. |
| 07/01/2021 | Date of grant for some employee stock options. |
| 12/05/2022 | Date of grant for some employee stock options. |
| 07/01/2022 | Date of grant for some employee stock options. |
| 07/01/2023 | Date of grant for some employee stock options. |
| 05/04/2024 | Date until which ESOP holdings are reported. |
| 07/01/2024 | Date of the reported transactions, including stock withholding, share acquisition, and RSU award. |
| 07/03/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.